The cannabigerol (cbg) gummies market has seen considerable growth due to a variety of factors.
• The cannabigerol (CBG) gummies market has grown exponentially in recent years. It will increase from $2.03 billion in 2024 to $2.96 billion in 2025, at a compound annual growth rate (CAGR) of 45.8%.
Growth drivers include cannabis legalization, consumer awareness, product innovation, and expanding distribution channels.
The cannabigerol (cbg) gummies market is expected to maintain its strong growth trajectory in upcoming years.
• The cannabigerol (CBG) gummies market is expected to grow rapidly to $13.25 billion by 2029, with a CAGR of 45.5%.
Growth drivers include evolving regulations, health and wellness trends, competitive market dynamics, and ongoing research and development. Trends include customization and personalization, premiumization, transparency and traceability, and diversified distribution channels.
The increasing prevalence of anxiety is expected to propel the growth of the cannabigerol (CBG) gummies market. With anxiety rates rising globally, CBG gummies, known for their potential stress-relieving properties, are seeing greater demand. In 2024, it was estimated that over 5.6 million Australians have experienced anxiety disorders, driving the growth of CBG gummies in the market.
The cannabigerol (CBG) gummies market covered in this report is segmented –
1) By Category: Cannabidiol (CBD) Edibles, Cannabigerol (CBG) And Cannabinol (CBN)
2) By Flavor: Raspberry Juice, Strawberry Juice, Cherry Juice, Strawberry Puree, Raspberry Powder, Other Flavors
3) By Form: Hard Candy, Soft Candy
Subsegments:
1) By Cannabidiol (Cbd) Edibles: Cbd Gummies, Cbd Chocolates, Cbd Beverages, Cbd Cookies And Biscuits, Cbd Hard Candies, Cbd Gummies For Sleep, Cbd Gummies For Pain Relief
2) By Cannabigerol (Cbg) And Cannabinol (Cbn): Cbg Gummies, Cbn Gummies, Cbg + Cbn Combined Gummies, Cbg Gummies For Sleep Or relaxation, Cbg Gummies For Focus And Clarity, Cbg Gummies For Pain And Inflammation, Cbg Gummies For Digestive Health
Companies in the cannabigerol (CBG) gummies market are creating wellness-focused products with natural ingredients to meet the demand for cannabinoid-based health products. For example, in November 2023, Rare Cannabinoid Company launched THC + CBG Relief Gummies, combining Delta-9-THC, CBG, and CBD to support physical well-being. Each gummy contains 2.5mg of Delta-9-THC, 30mg of CBG, and 10mg of CBD, offering a natural and enjoyable way to explore the benefits of these cannabinoids.
Major companies operating in the cannabigerol (CBG) gummies market are:
• Curaleaf Holding Inc.
• The Cronos Group
• Charlotte's Web Holdings Inc.
• Hemptown USA Inc.
• Green Roads LLC
• Lazarus Naturals Inc.
• Medterra CBD LLC
• ENDOCA
• Extract Labs
• NuLeaf Naturals LLC
• Isodiol International Inc.
• CBDistillery
• Elixinol Wellness Ltd.
• Joy Organics
• CBD American Shaman
• Steves GoodsIncredibles Edibles
• Vida Optima LLC
• CannaCare Health GmbH
• FAB Nutrition LLC (dba FAB CBD)
• Demetrix Inc.
• Rare Cannabinod Company
• Sunday Scaries
• CanniLabs
North America was the largest region in the cannabigerol (CBG) gummies market in 2024. The regions covered in the cannabigerol (CBG) gummies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.